154 related articles for article (PubMed ID: 24759403)
1. Mental health: Drug search on risky path.
Kell D
Nature; 2014 Apr; 508(7497):458. PubMed ID: 24759403
[No Abstract] [Full Text] [Related]
2. What lies beneath.
Nature; 2014 Mar; 507(7492):273. PubMed ID: 24654275
[No Abstract] [Full Text] [Related]
3. NIH rethinks psychiatry trials.
Reardon S
Nature; 2014 Mar; 507(7492):288. PubMed ID: 24646977
[No Abstract] [Full Text] [Related]
4. Mental health: More than neurobiology.
Fried E; Tuerlinckx F; Borsboom D
Nature; 2014 Apr; 508(7497):458. PubMed ID: 24759405
[No Abstract] [Full Text] [Related]
5. From Neurobiology to Novel Medications: A Principled Approach to Translation.
Gordon JA
Am J Psychiatry; 2019 Jun; 176(6):425-427. PubMed ID: 31154816
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics in psychiatry: clinical issues to be considered.
Licinio J; Wong ML
Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
[No Abstract] [Full Text] [Related]
7. The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and Progress.
Grabb MC; Hillefors M; Potter WZ
Pharmaceut Med; 2020 Aug; 34(4):233-245. PubMed ID: 32705569
[TBL] [Abstract][Full Text] [Related]
8. Does evidence from clinical trials in psychopharmacology apply in clinical practice?
Stahl SM
J Clin Psychiatry; 2001 Jan; 62(1):6-7. PubMed ID: 11235934
[TBL] [Abstract][Full Text] [Related]
9. [Off-label use of drugs in psychiatry and neurology].
Wallesch CW
Fortschr Neurol Psychiatr; 2004 May; 72(5):243-4. PubMed ID: 15136944
[No Abstract] [Full Text] [Related]
10. The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry.
Insel TR
Am J Psychiatry; 2014 Apr; 171(4):395-7. PubMed ID: 24687194
[No Abstract] [Full Text] [Related]
11. Clinical uses of benzodiazepines.
Hollister LE; Müller-Oerlinghausen B; Rickels K; Shader RI
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 1):1S-169S. PubMed ID: 7905883
[No Abstract] [Full Text] [Related]
12. Clinical trials in psychiatry.
Johnson AL
Psychol Med; 1983 Feb; 13(1):1-8. PubMed ID: 6844455
[No Abstract] [Full Text] [Related]
13. [Clinical studies with Glaziovin in the fields of internal medicine and neuropsychiatry].
Höffkes H; Leube H
Med Monatsschr; 1975 Jul; 29(7):321-5. PubMed ID: 1105121
[No Abstract] [Full Text] [Related]
14. [Use of peptides in psychiatry and neurology (review)].
Bulaev VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1244-8. PubMed ID: 3314286
[No Abstract] [Full Text] [Related]
15. [Multicenter psychopharmacologic research and the data bank].
Cassano GB; Conti L; Massimetti G
Acta Psychiatr Belg; 1983; 83(3):267-81. PubMed ID: 6356790
[TBL] [Abstract][Full Text] [Related]
16. Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC).
Kelly JR; Clarke G; Cryan JF; Dinan TG
Ir J Psychol Med; 2018 Jun; 35(2):89-94. PubMed ID: 30115193
[TBL] [Abstract][Full Text] [Related]
17. Hitting the target: a new framework for mental health trials.
Lancet; 2014 Mar; 383(9921):928. PubMed ID: 24629280
[No Abstract] [Full Text] [Related]
18. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
Muchnik S
Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
[No Abstract] [Full Text] [Related]
19. Caution on the potential usefulness of statins in neuropsychiatric diseases.
Brondino N; Emanuele E; Geroldi D
Med Hypotheses; 2007; 69(3):697. PubMed ID: 17350766
[No Abstract] [Full Text] [Related]
20. [Use of fenibut in psychiatry and neurology and its place among other psychotropic drugs (review of the literature)].
Khaunina RA; Lapin IP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):142-51. PubMed ID: 2665399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
